603387 logo

Getein Biotech, Inc Stock Price

SHSE:603387 Community·CN¥4.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603387 Share Price Performance

CN¥0
-7.95 (-100.00%)
CN¥0
-7.95 (-100.00%)
Price CN¥0

603387 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

2 Risks
2 Rewards

Getein Biotech, Inc Key Details

CN¥1.1b

Revenue

CN¥363.1m

Cost of Revenue

CN¥711.9m

Gross Profit

CN¥479.3m

Other Expenses

CN¥232.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.46
66.22%
21.64%
13.6%
View Full Analysis

About 603387

Founded
2002
Employees
1733
CEO
Enben Su
WebsiteView website
www.getein.com.cn

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection. The company was founded in 2002 and is headquartered in Nanjing, China.

Recent 603387 News & Updates

Recent updates

No updates